UK Markets open in 4 hrs 45 mins

e-Therapeutics plc (ETX.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
13.60-0.02 (-0.18%)
At close: 4:35PM BST
Currency in GBp

Valuation measures

Market cap (intra-day) 556.99M
Enterprise value 340.08M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)124.98
Price/book (mrq)800.00
Enterprise value/revenue 387.89
Enterprise value/EBITDA 6-14.11

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3445.00%
S&P500 52-week change 3N/A
52-week high 323.00
52-week low 31.25
50-day moving average 313.86
200-day moving average 311.36

Share statistics

Avg vol (3-month) 31.98M
Avg vol (10-day) 31.31M
Shares outstanding 5419.06M
Float 162.23M
% held by insiders 167.95%
% held by institutions 112.62%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Jan 2020
Most-recent quarter (mrq)31 Jan 2020


Profit margin 0.00%
Operating margin (ttm)-633.33%

Management effectiveness

Return on assets (ttm)-29.36%
Return on equity (ttm)-41.53%

Income statement

Revenue (ttm)456k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)509.10%
Gross profit (ttm)456k
Net income avi to common (ttm)-2.35M
Diluted EPS (ttm)-0.90
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.84M
Total cash per share (mrq)0.01
Total debt (mrq)69k
Total debt/equity (mrq)1.53
Current ratio (mrq)17.56
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-2.03M
Levered free cash flow (ttm)-1.48M
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more